Revision Process for Global/National Pharmacopoeias (PDF)

The pharma industry is focused on strengthening its foundation, embracing innovation, and future-proofing its path forward.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

The company said that Vyvgart (efgartigimod alfa) is the first novel mechanism of action for CIDP treatment in more than 30 years.

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

The policy announced by Commissioner Martin A. Makary, MD, will not preclude employees of regulated companies from presenting their views to committees, and rare exceptions will be allowed.

The recombinant vaccine, under the brand name Vimkunya, is recommended for persons age 12 and older who are traveling to a country or territory where there is a chikungunya outbreak.